Brugada Syndrome: Overview
Charles Antzelevitch(Lankenau Institute for Medical Research), A. A. M. Wilde, Han L. Tan(Howard Hughes Medical Institute), Pedro Brugada(Onze Lieve Vrouwziekenhuis Hospital), Josép Brugada(Hospital Clínic de Barcelona), Domenico Corrado(University of Padua), Martin Borggrefe(University of Padua), Hervé Le Marec(Centre National de la Recherche Scientifique), Eric Schulze‐Bahr(University of Münster), R. Brugada, Ihor Gussak, Koonlawee Nademanee(Bumrungrad International Hospital), Wataru Shimizu(Nippon Medical School Hospital)
Cited by 5
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|Circulation|2010|2.7k
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
|European Heart Journal|2018|2.1k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k